News
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...
1d
MedPage Today on MSNACIP Endorses RSV Vaccine for At-Risk Adults 50 and UpThe CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
CDC panel expands RSV vaccine recommendations for at-risk adults aged 50-59, including Pfizer's Abrysvo. Read more here.
With the arrival of spring the most severe phase of the 2024-25 respiratory illness has officially come to an end, according to the Grant County Health District. "Since March 2025, emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results